Second Sleep: The Medieval Intermission Your Body Still Remembers | Greg Licholai Wake up after midnight? Don’t worry—you’re in good company. From Odysseus to 14th-century monks, people once embraced a quiet or even productive interlude before returning to their ‘second sleep.’ So ...

Wake up after midnight? Don’t worry—you’re in good company. From Odysseus to 14th-century monks, people once embraced a quiet or even productive interlude before returning to their ‘second sleep.’ So enjoy the pause and maybe even dream of Penelope!

www.linkedin.com/posts/greg-l...?

🧪The Rise of the Randomized Controlled Trial (RCT): The Power of Nothing Long before “evidence-based medicine” became dogma, doctors practiced its opposite—with confidence. In the 18th and 19th centuries, the most potent drugs often did little, and the least potent sometim...

From citrus tests aboard 18th-century ships to today’s randomized controlled trials, the RCT transformed healing from ritual into science—revealing that even “nothing” could be powerful when measured with rigor. www.linkedin.com/pulse/rise-r...?

Digital twins are now being explored as tools to improve surgical planning, reduce errors, and even assist robotic procedures in real time. These virtual replicas of physical systems that learn, simulate, and predict performance.
www.forbes.com/sites/gregli...

💊 America’s Medicine Future: Can We Still Lead the World in Drug Discovery? For most of the past century, the United States has been the superpower of medical innovation. Our universities, entrepreneurs, and regulators built the modern pharmaceutical industry—and gave the wor...

The U.S. once set the global pace in drug discovery. Now, as China accelerates and our own innovation engine slows under regulation, the question isn’t can we lead again—it’s whether we’ll have the courage to reinvent how we govern science itself.
www.linkedin.com/pulse/americ...?

Blood Test Detects Dozens Of Cancers Early Blood Test Breakthrough Detects Dozens of Cancers Early With Unprecedented Accuracy

New blood test capable of detecting more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials to date
www.forbes.com/sites/gregli...

💊Would America Approve One of the World’s Most Common Medicines Today? Imagine this: aspirin is discovered in 2025. A simple molecule, easy to synthesize, promising to relieve pain, reduce fever, and even prevent heart attacks.

Would America approve one of the world’s most common medicines today?
More at www.licholai.com
www.linkedin.com/pulse/would-...

Pfizer Bets Big On Obesity Market Pfizer $4.9 billion cash acquisition of Metsera, a clinical-stage biotech focused on next-generation obesity drugs

Pfizer plants a big flag in the obesity market and makes huge bet on Metsera
www.forbes.com/sites/gregli...

Predicting Human Disease With Generative Models Researchers use generative AI to predict individual health risks

For the first time researchers have used generative AI to predict individual health risks. This is a scientific milestone for the future of medicine, prevention, and policy.
www.forbes.com/sites/gregli...

Reclaiming America’s Drug Innovation Edge Decline of American leadership in drug innovation

American leadership in developing innovative medicines is getting bogged down but REGULATORY PRAGMATISM can have quick impact.

www.forbes.com/sites/gregli...